It is clear from the available literature that much of the evidence supporting treatment recommendations for uremic bleeding comes from studies performed 25–30 years ago. At that time ...
Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects ...
Hemolytic uremic syndrome is a devastating, life-threatening thrombotic microangiopathy characterized by the triad of thrombocytopenia, microangiopathic hemolytic anemia, and renal failure. The ...
Atypical hemolytic uremic syndrome is an ultra-rare genetic disease that causes anemia and damages kidney function. There is an approved treatment — a therapeutic antibody called eculizumab ...